20 June 2013
Keywords: usa, already, losing, biogenerics, race, senate, panel
Article | 05 July 2004
The US Congress should design a fast-track process for approving genericversions of biologic therapies, but only if it is based ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 July 2004
12 July 2004
19 June 2013
© 2013 thepharmaletter.com